SCHEMBL30677376

SCHEMBL30677376

Cc1cccc(C=NNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.51
RAB9A P51151 10/20 0.51
SMN1; SMN2 Q16637 7/20 0.51
LMNA P02545 4/20 0.51
KDM4E B2RXH2 4/20 0.49
MAPT P10636 10/20 0.48
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.48
MAPK1 P28482 2/20 0.48
GAA P10253 5/20 0.45
POLB P06746 1/20 0.44
XBP1 P17861 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
GSK3B P49841 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467469 0.85 RAB9A (0.51) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467476 0.85 RAB9A (0.51) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467339 0.85 RAB9A (0.51) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467611 0.85 NPC1 (0.60) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467604 0.85 NPC1 (0.60) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467332 0.85 RAB9A (0.51) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467763 0.84 RAB9A (0.56) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467761 0.84 RAB9A (0.56) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3466886 0.82 RAB9A (0.51) NPC1RAB9ASMN1; SMN2LMNAKDM4E
SCHEMBL3467404 0.82 RAB9A (0.48) NPC1RAB9ASMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024014885-A1 NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF 일동제약(주) 2024-01-18 WO disclosed